← Back to patent-cliff list
CAS 463-78-5
methanetriol
Codes：DECI-004
Application context (from source-drug indications)
过敏反应地西他滨睫状肌麻痹地西他滨低血压地西他滨急性髓细胞样白血病地西他滨骨髓增生异常综合征地西他滨弥漫性大B-细胞淋巴瘤地西他滨
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 地西他滨Decitabine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
((2R,3S)-3-acetoxy-5-isocyanatotetrahydrofuran-2-yl)methyl acetate→methyl carbamimidothioate→((2R,3S)-3-acetoxy-5-(3-((E)-amino(methylthio)methylene)ureido)tetrahydrofuran-2-yl)methyl acetate→methanetriol→((2R,3S,5R)-3-acetoxy-5-(4-(methylthio)-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.